Royal Bank of Canada’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,039
| Closed | -$7K | – | 7253 |
|
|
2023
Q2 | $7K | Buy |
1,039
+537
| +107% | +$3.62K | ﹤0.01% | 6136 |
|
|
2023
Q1 | $2K | Sell |
502
-14
| -3% | -$56 | ﹤0.01% | 6441 |
|
|
2022
Q4 | $2K | Sell |
516
-1,205
| -70% | -$4.67K | ﹤0.01% | 6497 |
|
|
2022
Q3 | $7K | Sell |
1,721
-172
| -9% | -$700 | ﹤0.01% | 6139 |
|
|
2022
Q2 | $10K | Sell |
1,893
-11
| -0.6% | -$58 | ﹤0.01% | 5940 |
|
|
2022
Q1 | $19K | Buy |
1,904
+1,198
| +170% | +$12K | ﹤0.01% | 6161 |
|
|
2021
Q4 | $7K | Buy |
706
+83
| +13% | +$823 | ﹤0.01% | 6624 |
|
|
2021
Q3 | $15K | Sell |
623
-39
| -6% | -$939 | ﹤0.01% | 6302 |
|
|
2021
Q2 | $26K | Sell |
662
-194
| -23% | -$7.62K | ﹤0.01% | 5932 |
|
|
2021
Q1 | $36K | Buy |
856
+148
| +21% | +$6.22K | ﹤0.01% | 5599 |
|
|
2020
Q4 | $30K | Buy |
708
+168
| +31% | +$7.12K | ﹤0.01% | 5338 |
|
|
2020
Q3 | $60K | Sell |
540
-787
| -59% | -$87.4K | ﹤0.01% | 4794 |
|
|
2020
Q2 | $143K | Buy |
1,327
+430
| +48% | +$46.3K | ﹤0.01% | 4190 |
|
|
2020
Q1 | $60K | Buy |
897
+48
| +6% | +$3.21K | ﹤0.01% | 4570 |
|
|
2019
Q4 | $71K | Buy |
+849
| New | +$71K | ﹤0.01% | 4681 |
|